Página 3 - Melhores Transplante de medula óssea médicos - TOP-88 médicos

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

A Professora Zila Zuckerman é especializada em hematologia e transplante de medula óssea no Centro Médico Rambam.

• Especialização em hematologia e transplantologia
• Qualificações de nível de Professor (titular) na área
• Atua em um centro médico de referência

A Professora Dina Ben-Yehuda chefia o Departamento de Hematologia no Centro Médico Hadassah, sendo pioneira em transplantes de medula óssea e terapia genética.

• Especializa-se em diagnóstico molecular para doenças sanguíneas malignas
• Homenageada com o Prémio do Chefe do Estado-Maior por serviço excecional
• Primeira mulher Decana da Escola de Medicina Hadassah
• Treinada no Memorial Sloan-Kettering Cancer Center em Nova Iorque
• Recipiente do "Healing with the Heart Award" (Prémio Curar com o Coração) pela excelência no cuidado ao paciente

Realizou mais de 3.500 transplantes de medula óssea – O Dr. Stepensky se concentra em salvar a vida de crianças no Centro Médico Hadassah.

• 20 anos de experiência em transplante de medula óssea pediátrico
• Reconhecido pela Forbes como um dos melhores médicos em 2018
• Especializa-se em doenças raras de câncer no sangue em crianças
• Conhecido entre os pacientes como aquele que 'transplanta a vida'

A Dra. Irina Zaidman é especialista em transplante de medula óssea pediátrico no Centro Médico Hadassah, com formação avançada em instituições de ponta em todo o mundo.

• Fellowship em TMO pediátrico no Hospital for Sick Children, em Toronto
• Membro da diretoria da Sociedade Israelense de Hemato-Oncologia Pediátrica
• Publicou diversos artigos sobre transplantes de medula óssea pediátricos
• Membro das sociedades europeias e americanas de TMO

O Dr. Spielberg é especialista em transplante de medula óssea no Assuta Medical Center, uma instalação líder em tratamentos hematológicos.

• Onco-hematologista com foco em transplantes de medula óssea
• Trabalha no Assuta Medical Center, conhecido por seus cuidados hematológicos avançados
• Dedicado ao tratamento de condições hematológicas complexas

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Chefe do maior programa de transplante de medula óssea da Itália, realizando mais de 90 transplantes alogênicos anualmente no San Raffaele. É um dos principais especialistas em linfoma do país.

• Lidera a Unidade de Transplante de Medula Óssea desde 2006
• Especializado em hematologia e medicina interna pela Universidade de Milão
• Publicou mais de 70 estudos sobre transplante e cânceres do sangue
• Membro da Sociedade Europeia de Transplante de Sangue e Medula Óssea

O Prof. Dr. Serdar Bedii Omay publicou mais de 65 artigos científicos sobre hematologia e transplante de medula óssea, contando com vasta experiência na área.

• Formado em hematologia molecular na Faculdade de Medicina Mie do Japão
• Professor de Hematologia nas Universidades Técnicas de Ege e Karadeniz
• Especializado em medicina interna e hematologia desde 1990
• Autor de 112 artigos apresentados em reuniões e 34 apresentações em conferências

Diretor da Unidade de Linfoma no San Raffaele – o Prof. Ferreri fundou a Fundação Italiana de Linfoma para estudos clínicos avançados.

• Diretor Adjunto de Hematologia Oncológica com mais de 20 anos de experiência
• Autor de mais de 300 artigos sobre o tratamento de linfoma
• Especializado em pesquisa de linfomas não Hodgkin
• Membro da Associação Europeia de Hematologia & American Society of Hematology